- Scheme Category:
- Equity Scheme >
- Sectoral/Thematic Funds
NAV: ₹ ↓ -1.08%
NAV chart
SMA (Simple Moving Average)
- 50 SMA
- 100 SMA
- 200 SMA
- 400 SMA
Returns
CAGR returns till date
CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option and its peers as on 22 May, 2026| Name | YTD | 1D | 1W | 1M | 3M | 1Y | 3Y | 5Y | 7Y | 10Y |
|---|---|---|---|---|---|---|---|---|---|---|
| ITI Pharma and Healthcare Fund - Regular Plan - Growth Option | 6.76% | -1.08% | -0.1% | 7.66% | 9.86% | 4.48% | 21.36% | - | - | - |
| SBI HEALTHCARE OPPORTUNITIES FUND - REGULAR PLAN -GROWTH | 11.79% | 0.71% | 1.76% | 9.34% | 11.79% | 12.17% | 27.6% | 16.01% | 22.79% | 13.29% |
| SBI ESG Exclusionary Strategy Fund - Regular Plan - Growth | -6.63% | 0.56% | 1.24% | -3% | -5.2% | -2.01% | 10.96% | 10.63% | 11.75% | 12.27% |
| SBI INFRASTRUCTURE FUND - REGULAR PLAN - GROWTH | 2.59% | 0.32% | 0.92% | 1.04% | 3.07% | 3.61% | 20.17% | 19.67% | 18.75% | 16.14% |
| SBI PSU Fund - REGULAR PLAN -Growth | 2.13% | -0.14% | -1% | -5.25% | -5.24% | 9.86% | 30.04% | 24.27% | 18.83% | 15.77% |
| SBI CONSUMPTION OPPORTUNITIES FUND - REGULAR - GROWTH | -8.11% | -0% | -1.17% | -4.91% | -3.85% | -8.07% | 9.38% | 13.57% | 14.07% | 14.1% |
Discrete returns (yearly)
| Year | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | - | - | - | - | - | - | -8.89% | 32.42% | 41.76% | -10.78% |
Discrete returns (monthly)
| Month | Jul 2025 | Aug 2025 | Sep 2025 | Oct 2025 | Nov 2025 | Dec 2025 | Jan 2026 | Feb 2026 | Mar 2026 | Apr 2026 |
|---|---|---|---|---|---|---|---|---|---|---|
| Returns | 2.32% | -1.92% | -1.63% | 2.13% | -1.19% | -2.59% | -6.96% | 6.8% | -4.76% | 7.57% |
Returns from spefic dates
| Description | CAGR returns from 26 Sep 2024 (Nifty 50 2024 high) |
|---|---|
| Returns | -0.72% |
Portfolio
Asset allocation
| Equity | Debt | Realestate | Commodities | Cash & Equivalents |
|---|---|---|---|---|
| 99.18% | 0.00% (Arbitrage: 0.00%) | 0.00% | 0.00% | 0.82% |
Equity
| Name | Symbol / ISIN | Sector | Weight % |
|---|---|---|---|
| Sun Pharmaceutical Industries Limited | SUNPHARMA (INE044A01036) | Pharmaceuticals & Biotechnology | 11.80% |
| Divi's Laboratories Limited | DIVISLAB (INE361B01024) | Pharmaceuticals & Biotechnology | 8.77% |
| Apollo Hospitals Enterprise Limited | APOLLOHOSP (INE437A01024) | Healthcare Services | 6.60% |
| Max Healthcare Institute Limited | MAXHEALTH (INE027H01010) | Healthcare Services | 5.50% |
| Torrent Pharmaceuticals Limited | TORNTPHARM (INE685A01028) | Pharmaceuticals & Biotechnology | 5.28% |
| Aurobindo Pharma Limited | AUROPHARMA (INE406A01037) | Pharmaceuticals & Biotechnology | 4.99% |
| Lupin Limited | LUPIN (INE326A01037) | Pharmaceuticals & Biotechnology | 4.20% |
| Laurus Labs Limited | LAURUSLABS (INE947Q01028) | Pharmaceuticals & Biotechnology | 3.65% |
| Alkem Laboratories Limited | ALKEM (INE540L01014) | Pharmaceuticals & Biotechnology | 3.12% |
| Fortis Healthcare Limited | FORTIS (INE061F01013) | Healthcare Services | 2.91% |
| Neuland Laboratories Limited | NEULANDLAB (INE794A01010) | Pharmaceuticals & Biotechnology | 2.66% |
| Aster DM Healthcare Limited | ASTERDM (INE914M01019) | Healthcare Services | 2.32% |
| Abbott India Limited | ABBOTINDIA (INE358A01014) | Pharmaceuticals & Biotechnology | 2.32% |
| Glenmark Pharmaceuticals Limited | GLENMARK (INE935A01035) | Pharmaceuticals & Biotechnology | 2.15% |
| Cohance Lifesciences Limited | COHANCE (INE03QK01018) | Pharmaceuticals & Biotechnology | 2.09% |
| Dr. Reddy's Laboratories Limited | DRREDDY (INE089A01031) | Pharmaceuticals & Biotechnology | 1.87% |
| Mankind Pharma Limited | MANKIND (INE634S01028) | Pharmaceuticals & Biotechnology | 1.85% |
| Sai Life Sciences Limited | SAILIFE (INE570L01029) | Pharmaceuticals & Biotechnology | 1.82% |
| IPCA Laboratories Limited | IPCALAB (INE571A01038) | Pharmaceuticals & Biotechnology | 1.70% |
| Cipla Limited | CIPLA (INE059A01026) | Pharmaceuticals & Biotechnology | 1.67% |
| Park Medi World Limited | INE119201023 | Healthcare Services | 1.49% |
| Linde India Limited | LINDEINDIA (INE473A01011) | Chemicals & Petrochemicals | 1.39% |
| Biocon Limited | BIOCON (INE376G01013) | Pharmaceuticals & Biotechnology | 1.29% |
| SBI Life Insurance Company Limited | SBILIFE (INE123W01016) | Insurance | 1.25% |
| Healthcare Global Enterprises Limited | HCG (INE075I01017) | Healthcare Services | 1.24% |
| Sumitomo Chemical India Limited | SUMICHEM (INE258G01013) | Fertilizers & Agrochemicals | 1.21% |
| FDC Limited | FDC (INE258B01022) | Pharmaceuticals & Biotechnology | 1.16% |
| Onesource Specialty Pharma Limited | ONESOURCE (INE013P01021) | Pharmaceuticals & Biotechnology | 1.15% |
| Rainbow Childrens Medicare Limited | RAINBOW (INE961O01016) | Healthcare Services | 1.11% |
| Shaily Engineering Plastics Limited | SHAILY (INE151G01028) | Consumer Durables | 1.11% |
| Piramal Pharma Limited | PPLPHARMA (INE0DK501011) | Pharmaceuticals & Biotechnology | 1.10% |
| Jubilant Ingrevia Limited | JUBLINGREA (INE0BY001018) | Chemicals & Petrochemicals | 1.06% |
| GlaxoSmithKline Pharmaceuticals Limited | GLAXO (INE159A01016) | Pharmaceuticals & Biotechnology | 1.00% |
| Orchid Pharma Limited | ORCHPHARMA (INE191A01027) | Pharmaceuticals & Biotechnology | 0.83% |
| Shilpa Medicare Limited | SHILPAMED (INE790G01031) | Pharmaceuticals & Biotechnology | 0.82% |
| Standard Engineering Technology Ltd | SGLTL (INE0M4D01010) | Industrial Manufacturing | 0.82% |
| Caplin Point Laboratories Limited | CAPLIPOINT (INE475E01026) | Pharmaceuticals & Biotechnology | 0.74% |
| Zydus Lifesciences Limited | ZYDUSLIFE (INE010B01027) | Pharmaceuticals & Biotechnology | 0.69% |
| AstraZeneca Pharma India Limited | ASTRAZEN (INE203A01020) | Pharmaceuticals & Biotechnology | 0.69% |
| Poly Medicure Limited | POLYMED (INE205C01021) | Healthcare Equipment & Supplies | 0.68% |
| Supriya Lifescience Limited | SUPRIYA (INE07RO01027) | Pharmaceuticals & Biotechnology | 0.67% |
| Syngene International Limited | SYNGENE (INE398R01022) | Healthcare Services | 0.41% |
Debt
| Name | Rating | Weight % |
|---|
Portfolio data is as on date 31 March, 2026
NAV history
ITI Pharma and Healthcare Fund - Regular Plan - Growth Option - 30 days NAV (Net asset value) history
| Date | NAV | % change |
|---|---|---|
| 22 May, 2026 | 16.7003 | -1.08% |
| 21 May, 2026 | 16.8825 | 0.33% |
| 20 May, 2026 | 16.8275 | 0.15% |
| 19 May, 2026 | 16.8020 | 0.43% |
| 18 May, 2026 | 16.7302 | 0.08% |
| 15 May, 2026 | 16.7165 | -0.08% |
| 14 May, 2026 | 16.7296 | 1.72% |
| 13 May, 2026 | 16.4468 | -0.07% |
| 12 May, 2026 | 16.4586 | -1.58% |
| 11 May, 2026 | 16.7230 | 0.59% |
| 8 May, 2026 | 16.6241 | 0.32% |
| 7 May, 2026 | 16.5706 | 0.51% |
| 6 May, 2026 | 16.4871 | 1.86% |
| 5 May, 2026 | 16.1856 | 0.23% |
| 4 May, 2026 | 16.1490 | 1.43% |
| 30 April, 2026 | 15.9207 | -0.02% |
| 29 April, 2026 | 15.9238 | 0.09% |
| 28 April, 2026 | 15.9093 | -0.03% |
| 27 April, 2026 | 15.9139 | 2.4% |
| 24 April, 2026 | 15.5409 | -1.15% |
| 23 April, 2026 | 15.7213 | 1.35% |
| 22 April, 2026 | 15.5126 | 0.3% |
| 21 April, 2026 | 15.4663 | 0.06% |
| 20 April, 2026 | 15.4564 | -0.3% |
| 17 April, 2026 | 15.5023 | 0.63% |
| 16 April, 2026 | 15.4048 | 0.08% |
| 15 April, 2026 | 15.3927 | 1.68% |
| 13 April, 2026 | 15.1382 | -0.5% |
| 10 April, 2026 | 15.2149 | 0.98% |
| 9 April, 2026 | 15.0678 |
FAQ (Frequently asked questions)
What is latest/current NAV/price of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The latest NAV of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option is 16.7003 as on 22 May, 2026.What are YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The YTD (year to date) returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 6.76% as on 22 May, 2026.What are 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 1 year returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 4.48% as on 22 May, 2026.What are 3 year CAGR returns of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option?
The 3 year annualized returns (CAGR) of ITI Pharma and Healthcare Fund - Regular Plan - Growth Option are 21.36% as on 22 May, 2026.